Home
Search
BIO International Convention   |   June 16-19, 2025

Speakers & Presenters

All Speakers
By Count|Alphabetical
  • Show All
By Count|Alphabetical
  • Show All
By Count|Alphabetical
  • Show All
Company Type
  • Show All
Main Therapeutic Focus
  • Show All
Development Phase of Primary Product
  • Show All
Search Speakers
All Speakers
Filter by letter
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Results
Michael Sitzman
US CHAIR LIFE SCIENCES PATENT LITIGATION, DLA PIPER LLP (US)
Theoretical Patent Thickets v. Data-Driven Patent Policy: Are Changes Necessary at the PTO & FDA?
Claire Skentelbery
DIRECTOR GENERAL, EUROPABIO
BioPharma & Bio Manufacturing: Changing the Narrative and Addressing Climate Challenges
Ana Slipicevic, PhD
CEO, ONE CARBON THERAPEUTICS AB
One-carbon Therapeutics AB
Stockholm, Sweden
Elizabeth Smith, PhD
CHIEF BUSINESS OFFICER, FZATA, INC.
Fzata, Inc.
Halethorpe, Maryland, United States
Robert Smith
SENIOR VICE PRESIDENT, GLOBAL GENE THERAPY BUSINESS, PFIZER INC.
Realizing the Promise of Gene Therapy and Gene Editing: Current Challenges, Opportunities and Trends
Charlotte Smith
SENIOR VICE PRESIDENT, PUBLIC AFFAIRS, TRAVERE
Accelerated Approval Under Pressure: What’s At Stake and What Can Be Done?
Kim Smith
SVP RESEARCH AND DEVELOPMENT, VIIV HEALTHCARE
Partnering To Get Ahead of Disease Together
VALERIO SOLDANI, ACA
HEAD OF THE FOREIGN INVESTMENTS ATTRACTION DEPARTMENT, ITALIAN TRADE AGENCY
Italian Trade Agency
Roma, Lazio, Italy
Danny Soon
CHIEF EXECUTIVE OFFICER; CONCURRENT EXECUTIVE DIRECTOR, CONSORTIUM FOR CLINICAL RESEARCH AND INNOVATION (CRIS); SINGAPORE CLINICAL RESEARCH INSTITUTE (SCRI)
Patient Diversity and Beyond: Tapping the Potential of the Asia Pacific for Clinical Trials
Paula Soteropoulos
VENTURE PARTNER, 5AM VENTURES
Planning for the Future: Building Inclusive Corporate Boards